IRGC Portugal organised two workshops in November 2012, at the Instituto Superior Técnico (IST) in Lisbon as part of a Research Workshop Series on Industrialization, Geography and Policy with the goal of understanding the risks of de-industrialization and the dynamics of technological change to build socioeconomic resilience.
WORKSHOP I (8 and 9 November, 2012): REGULATE TO BUILD CAPACITY
DAY 1: REGULATION AND TECHNOLOGICAL CAPACITY BUILDING: THE OIL INDUSTRY IN BRAZIL
DAY 2: INDUSTRIALIZATION AND TECHNICAL CHANGE: METHODS AND TOOLS
This workshop was organised in collaboration with:
- Brazil’s National Agency of Petroleum, Natural Gas and Biofuels (ANP)
- Instituto de Economia – Universidade federal do Rio de
- The MIT/Harvard Observatory for Economic Complexity
WORKSHOP II (28 and 29 November, 2012): INDUSTRIAL EVOLUTION DYNAMICS
Workshop outputs I: SOUTH Oil&Gas 2030
The ultimate goal of this initiative is to promote a consortium in the form of an Observatory for Risk Governance, Industrialization and Technological change, “SOUTH Oil&Gas 2030”, to stimulate sustainable offshore Oil&Gas related businesses. It is aimed to help improving our understanding of new innovation dynamics and thesustainable Oil&Gas industries in South Atlantic and Sub-‐Saharan Africa.
Workshop outputs II: New Regulatory Frameworks towards harnessing knowledge, technology and innovation for sustainable Public Health
This study aims to identify, in a preliminary way, new forms of regulation of medicines including those for advanced therapies and of medical devices to be promoted and stimulated in Portugal and in a way to help harnessing knowledge, technology and innovation towards sustainable public health. It is based on a comparative analysis of emerging mechanisms of regulation (e.g., “intelligent and integrative”), discussed by the European Medicines Agency, EMA, and the Food And Drug Administration, FDA. These Mechanisms are likely to have a strong impact in the next decade in stimulating the adoption of new and advanced therapies, as well as new drugs, being the target of a discussion by emerging academic and medical communities.